The global kaposi sarcoma market is currently valued at more than USD 122 million and is expected to reach around USD 135 million by 2021, says Technavio. Technavio has announced its latest market research report on the global Kaposi sarcoma market, under its oncology portfolio. This market analysis discusses the major drivers and key emerging…
Technavio, a tech-focused market research firm, has published a new report on the global interventional oncology market, which is expected to grow at a CAGR of more than 11% during the forecast period, 2017-2021. Based on geographical segmentation, Technavio’s market researchers categorize the global interventional oncology market into the following key regions: the Americas, APAC,…
The global cancer monoclonal antibodies market was valued at USD 41 billion in 2015 and is expected to surpass USD 68 billion by 2021, says Technavio. Technavio has announced its latest market research report on the global cancer mAbs market, under its oncology portfolio. This market analysis discusses the major drivers and key emerging…
According to the latest market research study by Technavio, the global multiple myeloma drugs market is expected to grow at a CAGR of close to 9% during the forecast period 2017 to 2021. This report by Technavio provides an in-depth analysis of the global multiple myeloma drugs market in terms of revenue and emerging…
NSCLC is the largest disease segment in the global lung cancer therapeutics market and is expected to increase by 83% by 2020, says Technavio. Technavio has announced its latest market research report on lung cancer therapeutics for the forecast period, 2016-2020. This market analysis, under the oncology vertical, discusses the major drivers and key emerging trends…
Vendors to focus on the development of combination therapies for different types of leukemia Technavio, a company that develops over 2000 pieces of research every year and covers more than 500 technologies across 80 countries, has announced the top five leading vendors for the global leukemia therapeutics market in their latest research report. This…
Technavio, a tech-focused market research firm, has published a new report on the global ICP monitoring market, which is expected to experience a slow but steady growth rate with a CAGR of more than 7% during the forecast period. This latest report by Technavio covers the market outlook and growth prospects of the global…
Technavio, a company that develops over 2000 pieces of research every year and covers more than 500 technologies across 80 countries, has announced the top five leading vendors for the global breast cancer monoclonal antibodies market in their latest research report. This report also lists 11 other prominent vendors who are expected to contribute…
Solid tumors drugs: Key market research findings The Americas dominate the market geographically The biological segment accounts for a majority share of the market’s revenue Key vendors – Roche, Novartis, Celgene, Johnson & Johnson, Pfizer, and BMS Technavio’s market research analysts predict the global solid tumors drugs market to grow at a CAGR of…
CLL therapeutics: Key market research findings Special regulatory designations drive market growth The Americas dominate the market geographically Key vendors—F. Hoffmann-La Roche, AbbVie, Teva Pharmaceuticals, Johnson & Johnson, Gilead Sciences, and Novartis Technavio’s market research analysts predict the global CLL therapeutics market to grow at a CAGR of over 19% between 2016 and 2020….
